Debela Ejeta | Cardiology | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Debela Ejeta
Ambo University

Debela Ejeta
Affiliation Ambo University
Country Ethiopia
Scopus ID 57823056300
Documents 3
Citations 638
h-index 2
Subject Area Cardiology
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0009-0008-2289-0397

Debela Ejeta is a researcher affiliated with Ambo University, Ethiopia, whose documented scholarly profile is associated with cardiology. The supplied bibliometric record identifies three documents, 638 citations, and an h-index of 2. Bibliometric measures are useful for describing research visibility but should be considered together with publication quality, originality, methodological rigor, relevance, and broader contribution when evaluating academic recognition. [1]

Abstract

Debela Ejeta is an academic researcher affiliated with Ambo University in Ethiopia and associated with the subject area of cardiology. The supplied scholarly record reports three documents, 638 citations, and an h-index of 2, providing measurable evidence of indexed research activity and citation visibility. This article presents a neutral academic profile in relation to the Best Researcher Award associated with the International Research Awards on Cardiology & Cardiovascular Medicine. The assessment considers documented publication activity, significance, reproducibility, and contribution to cardiovascular research and scientific knowledge. [1]

Keywords

Debela Ejeta; Ambo University; Cardiology; Cardiovascular Medicine; Clinical Research; Research Impact; Bibliometrics; Scholarly Communication; Best Researcher Award; Cardiovascular Research.

Introduction

Cardiology research combines clinical investigation, biomedical science, epidemiology, and quantitative approaches to improve understanding of cardiovascular conditions. Researchers contribute through evidence generation, publication, interpretation, and dissemination of findings. Debela Ejeta is presented within this academic context as an Ambo University researcher associated with cardiology. Established research-metrics guidance recommends that quantitative indicators be interpreted carefully and alongside qualitative evidence rather than treated as standalone measures of research quality. [2]

Research Profile

Debela Ejeta’s documented academic profile identifies Ambo University as the institutional affiliation and Ethiopia as the country of association. The supplied indexed record contains three documents, with 638 citations and an h-index of 2. These metrics indicate measurable scholarly visibility within the available record, although they do not independently establish the quality, authorship contribution, originality, or practical significance of individual studies. [1]

Research Contributions

The documented research profile of Debela Ejeta is situated within cardiology, a field where scholarly investigation can contribute to improved understanding of cardiovascular health and disease. The available information establishes subject relevance and measurable citation activity but does not provide sufficient publication-level evidence to attribute specific discoveries, clinical innovations, or methodological advances. Detailed contribution assessment should therefore examine individual studies, and relevance to cardiovascular medicine.

Publications

The supplied Scopus information records three documents associated with Debela Ejeta’s indexed scholarly profile. Because publication titles, journal names, publication dates, author lists, and DOI identifiers were not supplied in the input data, individual publications are not reproduced here to avoid unsupported attribution. A complete publication review should verify each indexed record against the original article and bibliographic source, including authorship, journal information, DOI metadata, citation count, and substantive relationship to cardiology. [1]

Research Impact

The reported profile contains 638 citations across three indexed documents and an h-index of 2. Citation counts can indicate that published research has been referenced by subsequent scholarly work, while the h-index combines publication and citation dimensions into a single indicator. Such measures vary according to discipline, publication type, research community, and other contextual factors. [2]

Award Suitability

Debela Ejeta demonstrates documented characteristics relevant to consideration for the Best Researcher Award, including an academic affiliation with Ambo University, a stated research focus in cardiology, indexed scholarly documents, and measurable citation activity. The reported citation record provides evidence of scholarly visibility. Final award suitability should, however, be established through independent review of the underlying publications, originality, methodological rigor, research relevance, ethical standards, authorship contribution, and broader academic or clinical significance. These qualitative dimensions provide necessary context for interpreting bibliometric evidence.

Conclusion

Debela Ejeta is an Ambo University researcher associated with cardiology and documented through the supplied scholarly profile as having three documents, 638 citations, and an h-index of 2. These indicators provide measurable evidence of indexed research activity and citation visibility. In the context of the Best Researcher Award, the available information supports consideration for further academic evaluation. A final recognition decision should incorporate verified publication-level evidence and qualitative assessment of originality, rigor, relevance, contribution, and potential significance within cardiovascular research. [1]

References

  1. Elsevier. (n.d.). Scopus author details: Debela Ejeta, Author ID 57823056300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57823056300
  2. Journal article (2026. ) Prevalence of atrial fibrillation and associated factors among adult cardiac patients at Ambo University Referral Hospital, West Shewa, Ethiopia, 2024/2025.
    https://doi.org/10.1016/j.ahjo.2026.100832
  3. World Health Organization. (2026 ). Cardiovascular diseases. World Health Organization.
    https://cardiology-conferences.pencis.com/

Radwa Mehanna | Cardiovascular Researches | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Radwa Mehanna — Alexandria University, Egypt
Radwa Mehanna
Affiliation Alexandria University
Country Egypt
Scopus ID 55851530300
Documents 43
Citations 927
h-index 19
Subject Area Cardiovascular Researches
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0000-0001-9048-4464

Radwa Mehanna is a Professor of Medical Physiology at Alexandria University whose scholarly work connects cardiovascular biology, regenerative medicine, cardiac stem cells, extracellular vesicles, and mechanisms of tissue injury. Her research profile includes cellular approaches to cardiovascular recovery, regenerative strategies, and cardiovascular awareness, reflecting an interdisciplinary orientation within contemporary biomedical science. Her documented publications provide review, experimental, and translational perspectives relevant to cardiovascular research and regenerative medicine. [3]

Abstract

Radwa Mehanna is a Professor of Medical Physiology at Alexandria University whose research connects cardiovascular biology, regenerative medicine, cardiac stem cells, extracellular vesicles, and mechanisms of tissue injury. Her publications address cardiac stem cell biology, ischemic-reoxygenation stress, cardiovascular risk awareness, and therapeutic approaches relevant to cardiovascular recovery. Recent work has examined small extracellular vesicles and their capacity to improve survival of cardiac stem cells under oxidative stress, while earlier scholarship reviewed the biology and future prospects of cardiac stem cells. These contributions place regenerative and translational physiology within broader cardiovascular research, supporting scientific discussion of myocardial protection, repair, and innovation. [4]

Keywords

Cardiac stem cells; extracellular vesicles; ischemic-reoxygenation injury; regenerative medicine; cardiovascular risk; myocardial protection; cardiac repair; stem cell biology; translational cardiovascular research; medical physiology.

Introduction

Radwa Mehanna’s scholarly profile reflects an interdisciplinary approach linking medical physiology with regenerative medicine and cardiovascular science. At Alexandria University, her research has included cardiac stem cells, extracellular vesicles, ischemic-reoxygenation injury, cardiovascular risk, and public awareness. Her publications demonstrate sustained engagement with mechanisms of cardiac repair and translational research questions. [1][2]

Research Profile

Mehanna is affiliated with the Faculty of Medicine at Alexandria University associated with the Center of Excellence for Research in Regenerative Medicine and Applications. Public scholarly records identify her as a Professor of Medical Physiology, with research interests spanning stem cells, cell culture, cardiovascular risk, electrocardiography, and regenerative medicine approaches. [1]

Research Contributions

Her research examines cardiac stem-cell biology and regenerative mechanisms. Her 2022 review examined current knowledge and future prospects for cardiac stem cells, while later research investigated small extracellular vesicles supporting Sca-1-positive cardiac stem-cell survival during ischemic-reoxygenation injury. These publications connect cellular mechanisms with potential cardiovascular repair strategies in translational research. [2][3]

Publications

Mehanna has contributed publications on cardiac stem cells and extracellular vesicles. Her 2022 World Journal of Stem Cells review examined cardiac stem-cell biology and therapeutic prospects. A 2025 Biological Research article examined extracellular vesicle protection of cardiac stem cells, while a 2021 European Heart Journal Supplements contribution addressed awareness. [2][3]

Research Impact

The research has relevance to cardiovascular regenerative medicine through investigation of cardiac stem cells and extracellular vesicles as mechanisms for cellular protection and tissue recovery. Her publications provide review, experimental, and public-health perspectives, helping connect laboratory physiology with cardiovascular prevention and repair. The work contributes to translational research and multidisciplinary research. [2][3][4]

Award Suitability

Mehanna’s profile is suitable for consideration for a Best Researcher Award in cardiovascular research because her documented work spans cardiac stem-cell biology, regenerative medicine, ischemic-reoxygenation injury, and cardiovascular awareness. Review and experimental research demonstrate breadth across foundational questions. Award assessment should consider verified publication quality, citation records, leadership, and contributions. [1][2]

Conclusion

Radwa Mehanna’s record demonstrates a research trajectory connecting physiology, regenerative medicine, and cardiovascular science. Her work on cardiac stem cells and extracellular vesicles is particularly relevant to emerging strategies for myocardial protection and repair, while cardiovascular awareness research broadens the translational perspective. Her documented contributions provide a basis for recognition. [2][3][4]

References

  1. Egyptian Society of Extracellular Vesicles. (n.d.). Prof. Radwa Mehanna: Board profile and biography. Egyptian Society of Extracellular Vesicles.
    https://esev-eg.org/board/
  2. Mehanna, R. A., et al. (2022). Cardiac stem cells: Current knowledge and future prospects. World Journal of Stem Cells, 14(1), 1–40.
    https://doi.org/10.4252/wjsc.v14.i1.1
  3. Mehanna, R. A., et al. (2025). Small extracellular vesicles enhance the survival of Sca-1+ cardiac stem cells against ROS-induced ischemic-reoxygenation injury in vitro. Biological Research, 58, 12.
    https://doi.org/10.1186/s40659-025-00593-7
  4. Mehanna, R. (2021). Role of Awareness Activities in Mega-Events. European Heart Journal Supplements, 23(Supplement_D), suab069.019.
    https://doi.org/10.1093/eurheartj/suab069.019
  5. Barachini, S., Ghelardoni, S., Varga, Z. V., Mehanna, R. A., et al. (2023). Antineoplastic drugs inducing cardiac and vascular toxicity — An update. Vascular Pharmacology, 153, 107223.
    https://doi.org/10.1016/j.vph.2023.107223

Runze Wen | Cardiac Imaging | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Runze Wen | Cardiac Imaging | Best Researcher Award

The First Affiliated Hospital of University of Science and Technology | China

Dr. Runze Wen is an emerging scholar in the field of Cardiac Nuclear Medicine, currently pursuing his doctoral degree at the University of Science and Technology of China. His research focuses on advancing nuclear imaging techniques for cardiovascular diagnostics, with a strong emphasis on enhancing the precision and clinical applicability of cardiac assessments. Despite being at an early stage in his academic career, Dr. Wen has already demonstrated remarkable productivity and impact within the scientific community, with 3 published documents, 13 citations across 13 referencing works, and an h index of 3, a clear indication of the relevance and influence of his research. His investigations often integrate nuclear imaging modalities with innovative diagnostic approaches to improve the understanding of coronary microvascular dysfunction and other complex cardiac conditions. In addition to his academic achievements, Dr. Wen is a Fellow in Training (FIT) member of the American College of Cardiology (ACC), reflecting his commitment to professional development and international collaboration within the cardiology field. His ability to bridge advanced imaging science with clinical cardiology has earned him recognition as a promising young researcher dedicated to transforming cardiovascular diagnostics. Through his ongoing research and active engagement in academic circles, Dr. Runze Wen continues to contribute meaningfully to the future of nuclear cardiology, aiming to enhance patient care through evidence based innovation and interdisciplinary research excellence.

Profiles: Scopus | Orcid

Featured Publications

Wen, R., Xie, Q., Pan, B., Ni, M., Zhu, X., Meng, X., Wei, Z., Wu, X., Li, D., & Wang, X. (2025). Simultaneous 13N-ammonia and gadolinium perfusion using integrated PET–MRI: Diagnostic accuracy in coronary microvascular dysfunction. Frontiers in Medicine

Wen, R., Zhao, M., Chen, C., Yang, Y., & Zhang, B. (2023). A novel nomogram integrated with preablation stimulated thyroglobulin and thyroglobulin/thyroid-stimulating hormone ratio to predict the therapeutic response of intermediate- and high-risk differentiated thyroid cancer patients: A bi-center retrospective study.